HOLOGIC INC (HOLX) Stock Price, Quote, News and Overview
NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock
HOLX Quote and Key Statistics
HOLOGIC INC
NASDAQ:HOLX (1/22/2025, 10:28:09 AM)
70.86
+0.49 (+0.7%)
HOLX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.59% | ||
| ROA | 8.62% | ||
| ROE | 15.39% | ||
| Debt/Equity | 0.49 |
HOLX Performance and Technical Analysis
HOLX Ownership and Analysts
HOLX Latest News and Analysis
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
FDA Warns Hologic Over BioZorb Manufacturing Violations
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
Hologic Completes Acquisition of Gynesonics, Inc.
About HOLX
Company Profile
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts. The company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics segment offers a range of diagnostic products, which are used to aid in the screening and diagnosis of human diseases. Breast Health segment offers a portfolio of solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment. The company also offers wireless breast surgery localization and lymphatic tracing solutions. GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
Company Info
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS 01752 US
CEO: STEPHEN P. MACMILLAN
Employees: 6990
Company Website: https://www.hologic.com/
Investor Relations: https://investors.hologic.com
Phone: 15082632900
HOLX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 91.05 | 217.92B | ||
| ABT | ABBOTT LABORATORIES | 26.04 | 204.12B | ||
| SYK | STRYKER CORP | 33.91 | 150.46B | ||
| BSX | BOSTON SCIENTIFIC CORP | 42.87 | 149.11B | ||
| MDT | MEDTRONIC PLC | 16.81 | 113.15B | ||
| BDX | BECTON DICKINSON AND CO | 18.1 | 69.08B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.99 | 40.92B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.69 | 39.89B | ||
| RMD | RESMED INC | 29.95 | 36.45B | ||
| IDXX | IDEXX LABORATORIES INC | 39.21 | 35.15B | ||
| DXCM | DEXCOM INC | 50.99 | 33.86B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 20.01 | 25.02B |